The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...
Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...
An insurance trust utilized by 80 school districts in the state, mostly in Southern Illinois, has fallen $7 million in the ...
Exelixis, Inc. (NASDAQ:EXEL) authorized repurchasing up to an additional $500 million of the company’s common stock before December 31, 2025. Exelixis plans to complete the $500 million stock ...
The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.
The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...
The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...
The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results